Losartan Potassium
Product Images NDC 50090-5406

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-5406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 01)

FDA Label Image

Image002 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 02)

Image002 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 02)
This is a medical research report that displays the results of patients treated with Atenolol and Losartan Potassium drugs. The report states the adjusted risk reduction percentage, which is 13%, with a p-value of 0.021. The horizontal axis shows different study months (from 6 to 66) while there's no clear information about the vertical axis.*
FDA Label Image

Image003 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 03)

Image003 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 03)
This text is not available to generate a useful description as it contains incomplete and unclear information.*
FDA Label Image

Image004 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 04)

Image004 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 04)
This is a tabular representation of the results of a study comparing the effectiveness of Losartan and Atenolol in reducing the incidence of Primary Composite Stroke among patients. The table shows the number of patients who experienced the outcome under consideration, the rate of the outcome, the hazard ratio, and 95% confidence interval for Losartan and Atenolol treatments. The patients are also categorized based on age, gender, race, history of CVD, diabetes, and other factors. The details of the study are not available.*
FDA Label Image

Image005 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 05)

Image005 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 05)
The data represents the percentage of patients who experienced an event, along with the associated risk reduction percentage and p-value. There is no information on what type of event is being measured, and the numbers 40 and 20 do not provide any context.*
FDA Label Image

Label Image (Lbl500905406)

Label Image (Lbl500905406)
This is a product description for LoF' LiSharan rorassiun, which comes in a 30 tablet container (Product No. 6394-0). The recommended storage temperature is 7°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.